Dendritic cells (DC) are professional antigen-presenting cells with a key function in the immune system as initiators of T-cell responses against microbial pathogens and tumors. Therefore, the immunization using DC loaded with tumorassociated antigens is potential to represent a powerful method of inducing anti-tumor immunity. Recent studies have demonstrated the usefulness of DC genetically modiˆed by adenovirus vectors (Ad) to immunotherapy, while su‹cient gene transduction into DC is required for high doses of Ad. Entry of Ad into target cells occurs by serial two steps: the binding of Ad-ˆber knob to Coxsackie-adenovirus receptor (CAR) on the cell surface, and the subsequent interaction between Arg-Gly-Asp (RGD) motif located in Ad-penton base and a v -integrins. The reverse transcription-polymerase chain reaction analysis revealed that the relative resistance of DC to Ad-mediated gene transfer was due to the absence of CAR expression, and that DC expressed adequate a v -integrins. Therefore, we investigated whetherˆber-mutant Ad (FM-Ad) containing the RGD sequence in theˆber knob can e‹ciently transduce and express high levels of the foreign gene into DC. The gene delivery by FM-Ad was more e‹cient than that by conventional Ad in both murine DC lines and normal human DC. Furthermore, both antigen presentations via major histocompatibility complex class I molecules and in vivo antigen-speciˆc cytotoxic T lymphocyte induction by DC transduced with antigen gene by FM-Ad were superior to those by DC applied with conventional Ad. We propose that a v -integrin-targeted FM-Ad is a very powerful tool to implement DC-based vaccination strategies.
Antigens are captured by immature DC in peripheral tissues and processed to form MHC-peptide complexes. As a consequence of antigen deposition and in‰ammation, DC begin to mature, expressing large amounts of MHC-peptides complexes on their surface. Additionally, they up-regulate co-stimulatory molecules and migrate to regional lymphoid tissues where they prime and activate antigen-speciˆc T cells. Vol. 121 (2001) 
